NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Next predicted deadline: Oct 10, 2023 (Full proposal)

Later predicted deadlines: Jan 7, 2024 (Full proposal), Feb 9, 2024 (Full proposal), May 7, 2024 (Full proposal)

Grant amount: Unspecified amount

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE: All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates:  February 09, 2023, June 09, 2023, October 10, 2023, and February 09, 2024, by 5:00 PM local time of the applicant organization. All types of AIDS and AIDS-related applicants allowed for this funding opportunity announcement are due on these dates:  January 07, 2023, May 07, 2023, September 07, 2023, January 07, 2024, May 07, 2024, by 5:00 PM local time of the applicant organization.

The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications for investigator-initiated efficacy clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The trials must address questions within the mission and research interests of the NINDS and may evaluate drugs, biologics, and devices, as well as surgical, behavioral and rehabilitation therapies. Information about the mission and research interests of the NINDS can be found at the NINDS website.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.